https://www.taxtmi.com/news?id=57011 A US trade measure imposes a 100 percent tariff on branded and patented pharmaceutical products unless the company is "is building" a manufacturing plant in the United States, where "is building" is defined as breaking ground or under construction; Indian exporters expect little impact because principal shipments to the US are generic medicines rather than patented branded drugs. en-us Fri, 26 Sep 2025 11:16:02 +0530 Fri, 26 Sep 2025 11:16:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=57011 A US trade measure imposes a 100 percent tariff on branded and patented pharmaceutical products unless the company is "is building" a manufacturing plant in the United States, where "is building" is defined as breaking ground or under construction; Indian exporters expect little impact because principal shipments to the US are generic medicines rather than patented branded drugs. News - Fri, 26 Sep 2025 11:16:02 +0530 https://www.taxtmi.com/news?id=57011